38 employees
Appia Bio is a biotechnology company that focuses on the research and development of off-the-shelf allogeneic cell therapies.
2020
$52M
from 5 investors over 5 rounds
Appia Bio raised $52M on May 11, 2021
Investors: 8VC, Bossa Nova Investimentos, Freeflow Ventures, Two Sigma Ventures and 夏尔巴股权投资管理有限公司